Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)
ID: 352698Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/352698

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-013.html
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Feb 29, 2024 12:00 AM
  4. 4
    Due Jul 30, 2024 12:00 AM
Description

The National Institutes of Health (NIH) has posted a grant opportunity titled "Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)". This grant aims to foster new multi-disciplinary teams to investigate how HIV comorbidities and co-infections interact with viral reservoirs, potentially affecting cure strategies. The teams will study the impact of inflammation, metabolic perturbations, and other pathophysiological processes associated with these conditions on reservoir dynamics, as well as the interplay between these conditions and co-infections on HIV reservoir biology. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The grant opportunity will close on July 30, 2024, and more information can be found at the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-013.html. For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
grantsinfo@nih.gov
Files
Title
Posted
RFA-DK-25-013-Full-Announcement.html
4/10/2024
Similar Opportunities
Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed)". This grant aims to support research that investigates the underlying mechanisms contributing to health disparities in HIV and aging, as well as how multiple comorbidities impact overall health outcomes and quality of life among individuals with HIV from populations experiencing health disparities. The grant does not require cost sharing or matching requirements and falls under the category of funding activity for health. The funding instrument type is a grant, and the opportunity category is discretionary. The CFDA number associated with this grant is 93.847. Eligible applicants for this grant include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. The grant has a closing date of January 7, 2026, and an award ceiling of $500,000. The description of the grant emphasizes the importance of understanding the mechanisms behind health disparities in HIV and aging, as well as the impact of comorbidities on the overall health outcomes and quality of life of individuals with HIV from populations experiencing health disparities. For more information and to apply for this grant opportunity, please visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-24-005.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-24-005.html). If you have any further inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)". This grant aims to support multilevel and multidisciplinary intervention research to improve the quality of life and promote successful aging among people with HIV who have HIV-associated non-AIDS comorbidities. The focus is on individuals from racial and ethnic backgrounds and lower socioeconomic status groups. The grant does not require cost sharing or matching. The funding instrument type is a grant, and the category of funding activity is health. The opportunity is posted under the discretionary category. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs). Non-domestic (non-U.S.) entities and components are not eligible to apply. The closing date for this grant opportunity is December 11, 2026. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-24-003.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-24-003.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R01 Clinical Trial Not Allowed)". This grant aims to examine the mechanisms of reciprocal interactions between HIV-associated neuroinflammation and CNS persistence in the setting of excellent virologic control. The research will utilize novel CNS cell systems, organoid models, and single cell technologies. The grant does not require cost sharing or matching. The funding instrument type is a grant, and the category of funding activity is health. The opportunity is posted on grants.gov and falls under the discretionary category. The CFDA number associated with this grant is 93.853. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, non-domestic (non-U.S.) entities, regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territories or Possessions, and non-domestic (non-U.S.) components of U.S. Organizations. The closing date for this grant opportunity is November 8, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-180.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-180.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)". This opportunity falls under the category of Health and is a Cooperative Agreement type of funding instrument. The grant does not require cost sharing or matching. The purpose of this grant is to support the development of clinical research platforms that will enable future clinical trials to determine whether combinations of HIV cure strategies can be effective when optimally tailored to the participants. The goal is to inform the development and prioritization of more broad-based curative strategies that will be effective in all people living with HIV. This grant will support multidisciplinary teams to conduct coordinated basic and pre-clinical research. The teams will profile participants' intact, rebound-competent HIV reservoirs and immunologic backgrounds and use that information to develop and test combinations of HIV curative approaches that are specifically tailored to those participants. The grant has a closing date of July 30, 2024, and an award ceiling of $2,000,000. Eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Organizations) and non-U.S. components of U.S. Organizations are not eligible to apply. For more information and to apply for this grant opportunity, please visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-011.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-011.html). If you have any inquiries, you can contact NIH Grants Information at grantsinfo@nih.gov.
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed)". This grant aims to examine the mechanisms of reciprocal interactions between HIV-associated neuroinflammation and CNS persistence in the setting of excellent virologic control. The research will utilize novel CNS cell systems, organoid models, and single cell technologies. The grant does not require cost sharing or matching. The funding instrument type is a grant, and the category of funding activity is health. The opportunity falls under the discretionary category and has a CFDA number of 93.853. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for this grant is November 8, 2024. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-181.html](http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-25-181.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.